Author: GlobeNewswire

NEW HAVEN, Conn., June 22, 2021 (GLOBE NEWSWIRE) — Bioasis Technologies Inc. (“Bioasis” or the “Company”) (TSX.V:BTI; OTCQB:BIOAF), a pre-clinical,…

MELBOURNE, Australia, June 22, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announces that a…

Company Announcement COPENHAGEN, Denmark; June 22, 2021 – Genmab A/S (Nasdaq: GMAB) announced today that at a board meeting the…

SAN DIEGO, June 22, 2021 (GLOBE NEWSWIRE) — Codex DNA, Inc. (Nasdaq: DNAY) today announced the closing of its initial…

Company announcement – No. 40/ 2021 Zealand Pharma to Participate in LifeSci Nordic Biotech Summit Copenhagen, DK and Boston, MA,…

TUSTIN, Calif., June 22, 2021 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization…

Mechelen, Belgium; 22 June 2021, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announces the departure of…

LEXINGTON, Mass., June 22, 2021 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on…

SOUTH SAN FRANCISCO, Calif., June 22, 2021 (GLOBE NEWSWIRE) — Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical company developing…

PHILADELPHIA, June 22, 2021 (GLOBE NEWSWIRE) — Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived…